Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,778.00
Bid: 1,774.00
Ask: 1,774.50
Change: -10.50 (-0.59%)
Spread: 0.50 (0.028%)
Open: 1,796.00
High: 1,808.50
Low: 1,772.50
Prev. Close: 1,788.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday broker round-up UPDATE

Fri, 22nd Feb 2013 07:12

Antofagasta: RBC upgrades from underperform to outperform.Ashmore Group: Citigroup raises target price from 330p to 355p upgrading to neutral. JP Morgan ups target price from 361p to 413p and maintains a neutral rating.Babcock International: Citigroup revises target price from 965p to 1185p and keeps its buy recommendation.BAE Systems: Deutsche Bank takes target price from 360p to 375p maintaining a buy recommendation. JP Morgan increases target price from 330p to 360p and retains a neutral rating.Barclays: Investec shifts target price from 340p to 345p and upgrades from hold to buy.BP: Canaccord Genuity downgrades from buy to hold with a target price of 500p.Bumi: JP Morgan reiterates underweight. Liberum reinitiates coverage at buy.British Sky Broadcasting: HSBC ups target price from 520p to 600p keeping an underweight rating.Capita Group: Citigroup moves target price from 870p to 990p, while leaving its buy recommendation unchanged.Chariot Oil & Gas: Jefferies ups target price from 36p to 50p and upgrades from hold to buy. Merchant Securities cuts target price from 29.20p to 20.60p, while reiterating a hold recommendation.CSR: UBS raises target price from 330p to 450p, while retaining a neutral rating. Deutsche Bank revises target price from 255p to 300p, while staying with its sell recommendation. JP Morgan takes target price from 450p to 475p and reiterates an overweight rating. Canaccord Genuity moves target price from 370p to 475p and keeps a buy recommendation.Drax Group: Goldman Sachs downgrades from buy to neutral.Filtrona: UBS increases target price from 600p to 660p and keeps a buy recommendation.Fresnillo: Societe Generale initiates with a target price of 1200p and a sell recommendation.GlaxoSmithKline: Jefferies moves target price from 1500p to 1550p and maintains a hold recommendation.Go-Ahead Group: HSBC revises target price from 1415p to 1485p, while staying with an overweight rating.G4S: HSBC shifts target price from 260p to 270p and downgrades to underweight.Halfords Group: UBS lowers target price from 290p to 280p and retains a sell recommendation.HSBC Holdings: Credit Suisse moves target price from 750p to 760p and keeps an outperform rating.Informa: Deutsche Bank shifts target price from 600p to 620p and leaves its buy recommendation unaltered. Citigroup takes target price from 520p to 550p reiterating a buy rating. Westhouse Securities ups target price from 493p to 525p and upgrades from neutral to add. Canaccord Genuity raises target price from 500p to 560p maintaining its buy recommendation. Investec increases target price from 495p to 520p keeping a hold recommendation.InterContinental Hotels Group: Citigroup increases target price from 1900p to 2200p retaining its buy recommendation.Interserve: Westhouse Securities raises target price from 432p to 537p, while downgrading from buy to add.Johnson Matthey: Morgan Stanley reduces target price form 2300p to 2200p retaining an underweight rating.Kingfisher: HSBC cuts target price from 340p to 335p and keeps its overweight rating.Lancashire: Nomura increases target price from 826p to 906p not altering its neutral rating.Millennium & Copthome: Credit Suisse moves target price from 524p to 542p and retains its neutral rating.Mondi: UBS ups target price from 720p to 840p, while leaving its neutral rating unchanged.Netplay: Merchant Securities initiates with a target price of 20p and a buy recommendation.New World Resources: JP Morgan shifts target price from 150p to 160p leaving its underweight rating unaltered.Old Mutual: JP Morgan raises target price from 186p to 209p, while downgrading to neutral.Pendragon: Panmure Gordon shifts target price from 15p to 19p and still recommends selling.Restaurant Group: Citigroup revises target price from 400p to 450p, while the buy recommendation is kept.REXAM: Credit Suisse shifts target price from 545p to 555p and stays with its neutral rating. Oriel Securities ups target prcie from 540p to 570p maintaining a buy recommendation.Sainsbury: Citigroup raises target price from 315p to 385p upgrading to buy.Serco Group: Citigroup shifts target price from 670p to 680p reiterating a buy recommendation.Shire: Morgan Stanley moves target price from 2350p to 2400p keeping an overweight rating.Spectris: N+1 Singer takes target price from 2135p to 2415p, while reiterating a hold recommendation. Investec ups target price from 2400p to 2575p and stays with its hold rating.Sports Direct International: Citigroup increases target price from 470p to 530p and still recommends buying.Whitbread: Citigroup raises target price from 2400p to 2675p and leaves its neutral rating unchanged. JP Morgan revises target price from 2650p to 2700p maintaining an overweight rating. Panmure Gordon ups target price from 1994p to 2500p, while reiterating a hold recommendation.William Hill: Jefferies raises target price from 370p to 500p keeping a buy recommendation.Xaar: Investec starts with a target price of 350p and a buy recommendation.
More News
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.